Jazz Pharmaceuticals JAZZ Income tax benefit realized from option exercises
Income tax benefit realized from option exercises at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions.
The official record: Jazz Pharmaceuticals’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's income tax benefit realized from option exercises.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's income tax benefit realized from option exercises?
- Jazz Pharmaceuticals (JAZZ) reported income tax benefit realized from option exercises of $1.25M in Q4 2025.
- How has Jazz Pharmaceuticals's income tax benefit realized from option exercises changed year-over-year?
- Jazz Pharmaceuticals's income tax benefit realized from option exercises increased by 1566.7% year-over-year, from $75K to $1.25M.
- What is the long-term trend for Jazz Pharmaceuticals's income tax benefit realized from option exercises?
- Over 4 years (2021 to 2025), Jazz Pharmaceuticals's income tax benefit realized from option exercises has grown at a -14.4% compound annual growth rate (CAGR), from $9.3M to $5M.
- What does income tax benefit realized from option exercises mean?
- The tax savings generated when employees exercise their stock options.
- How do you interpret income tax benefit realized from option exercises?
- Higher benefits indicate significant employee option exercise activity, which can improve cash flow through tax savings.
- How does income tax benefit realized from option exercises compare across companies?
- Common in companies with heavy equity-based compensation; varies based on stock price performance relative to grant prices.